Low Hemoglobin-To-Red Cell Distribution Width Ratio Is Associated With Disease Progression And Poor Prognosis In Upper Tract Urothelial Carcinoma

The importance of blood cell markers in patients with malignant tumors has been studied, but there are few studies on the prognostic value of hemoglobin-to-red cell distribution width ratio (HRR) in cancer. This is the first study to investigate the effect of preoperative HRR on patients with upper tract urothelial carcinoma (UTUC). Our retrospective cohort study included 730 UTUC patients who underwent nephroureterectomy from 2000 to 2019. Clinicopathological parameters were compared according to HRR levels, and the relationship between blood cell markers (HRR, white blood cell [WBC] count, platelet count) and prognosis was evaluated using Kaplan-Meier method and Cox regression model. We found that patients with HRR <= 1.05 tended to have worse renal function, higher pathological stages, and more high-grade tumors. In univariate analysis, HRR <= 1.05, WBC > 8.65 x 10(3) cells/mu L and platelets >309 x 10(3) cells/mu L were associated with poor progression-free survival (PFS), cancer-specific survival (CSS), and overall survival (OS). Multivariate analysis demonstrated that HRR <= 1.05 and WBC > 8.65 x 10(3) cells/mu L were independent prognostic factors for predicting deterioration of PFS, CSS, and OS. In conclusion, HRR and WBC are easy to obtain in clinical practice and are useful indicators to provide prognostic information before surgery for UTUC.